1 | Acthar high dose (80 U) | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 49 49 |
2 | Administration of a high dose of desipramine | 1件: Desipramine Desipramine | 2件: D00812
D00812
,
D07791
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 156 156 |
3 | Ambrisentan - high dose | 1件: Ambrisentan Ambrisentan | 1件: D07077
D07077
| 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
4 | AXO-AAV-GM2 High Dose | - | - | - | - | 1件: 19 19 |
5 | BI 655064 high dose | - | - | - | - | 1件: 46 46 |
6 | BIIL 284 BS high dose | - | - | - | - | 1件: 46 46 |
7 | BIIL 284 BS, high dose | - | - | - | - | 1件: 299 299 |
8 | BIIL 284 BS, high dose, adult patients | - | - | - | - | 1件: 299 299 |
9 | BIIL 284 BS, high dose, pediatric patients | - | - | - | - | 1件: 299 299 |
10 | BIRB 796 BS, high dose | - | - | - | - | 1件: 46 46 |
11 | BLI-1300 high dose | - | - | - | - | 1件: 96 96 |
12 | Brazikumab high dose | 1件: Brazikumab Brazikumab | 1件: D10912
D10912
| 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 |
13 | Clobazam High Dose | 1件: Clobazam Clobazam | 1件: D01253
D01253
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 144 144 |
14 | CVN424 High Dose | - | - | - | - | 1件: 6 6 |
15 | CVT-301 High Dose | - | - | - | - | 1件: 6 6 |
16 | DNS-7801 (high dose) | - | - | - | - | 1件: 6 6 |
17 | Elamipretide (high dose) | 1件: Elamipretide Elamipretide | 1件: D10925
D10925
| - | - | 1件: 21 21 |
18 | EUR-1008 (APT-1008) High Dose | - | - | - | - | 1件: 298 298 |
19 | Fentanyl (High Dose) | 1件: Fentanyl Fentanyl | 2件: D00320
D00320
,
D01399
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 215 215 |
20 | High dose | - | - | - | - | 1件: 97 97 |
21 | High dose AFFITOPE® PD03A + Adjuvant | - | - | - | - | 1件: 6 6 |
22 | High dose ANAVEX2-73 | - | - | - | - | 1件: 6 6 |
23 | High Dose Aspirin (1300 mg/day) | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: D00109
D00109
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 |
24 | High dose BIBF 1120 twice daily | - | - | - | - | 1件: 85 85 |
25 | High Dose Budesonide | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
26 | High dose budesonide suspension | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
27 | High dose budesonide tablet | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
28 | High dose Dexamethasone pulses | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 |
29 | High dose lactulose | 1件: Lactulose Lactulose | 1件: D00352
D00352
| - | - | 1件: 291 291 |
30 | High dose levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
31 | High Dose Mesenchymal Stem Cells (MSCs) | - | - | - | - | 1件: 49 49 |
32 | High Dose MT-1303 | - | - | - | - | 1件: 97 97 |
33 | High dose of BIIL 284 BS tablets | - | - | - | - | 1件: 46 46 |
34 | High dose of budesonide | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 |
35 | High dose ORTD-1 | - | - | - | - | 1件: 46 46 |
36 | High dose TSO | - | - | - | - | 1件: 96 96 |
37 | High dose vehicle control | - | - | - | - | 1件: 46 46 |
38 | High Dose-VIS649 | - | - | - | - | 1件: 66 66 |
39 | High doses of Thiamine y Biotin | 2件: Biotin Biotin, Thiamine | 2件: D00029
D00029
,
D08580
| - | - | 1件: 8 8 |
40 | HMPL-004 high dose | - | - | - | - | 1件: 97 97 |
41 | IgPro20 (high dose) | - | - | - | - | 1件: 14 14 |
42 | KPS-0373, High dose | - | - | - | - | 1件: 18 18 |
43 | KW-6356 High Dose | - | - | - | - | 1件: 6 6 |
44 | LiRIS low dose and LiRIS high dose | - | - | - | - | 1件: 226 226 |
45 | LX3305 high dose | - | - | - | - | 1件: 46 46 |
46 | M5049 high dose | - | - | - | - | 1件: 49 49 |
47 | MEDI7183 high dose | - | - | - | - | 1件: 97 97 |
48 | MMX Mesalamine/Mesalazine (High Dose) | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
49 | MT-1303 High dose | - | - | - | - | 1件: 49 49 |
50 | MT-7117 High Dose | - | - | - | - | 1件: 254 254 |
51 | MultiStem high dose | 1件: MultiStem MultiStem | - | - | - | 1件: 97 97 |
52 | Non-myeloablative high dose immunosuppressive therapy conditioning (HDIT) | - | - | - | - | 1件: 49 49 |
53 | OCU400 High Dose | - | - | - | - | 1件: 90 90 |
54 | PF-06649751 high dose (15 mg QD) | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
55 | PXT3003 High Dose | - | - | - | - | 1件: 10 10 |
56 | Ravicti high dose | 1件: Glycerol phenylbutyrate Glycerol phenylbutyrate | 1件: D10127
D10127
| - | - | 1件: 299 299 |
57 | SA001 High dose | - | - | - | - | 1件: 53 53 |
58 | SEN0014196 (High Dose) | - | - | - | - | 1件: 8 8 |
59 | SHR1459 High Dose | - | - | - | - | 1件: 222 222 |
60 | TAS5315 high dose | - | - | - | - | 1件: 46 46 |
61 | Vitamin D3 - high dose | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 6 6 |
62 | YRA-1909 high dose | - | - | - | - | 1件: 46 46 |